Saracatinib Trial TO Prevent FOP

Clinical trial NCT04307953 · UNKNOWN

Trial details

NCT number: NCT04307953
Sponsor: Amsterdam UMC, location VUmc
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Fibrodysplasia Ossificans Progressiva

Start date: 2020-08-05
Primary completion: 2025-05-06
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.